BIRC5 and medical procedure: High levels of TRAIL decoy receptor expression are associated with poor prognosis and resistance to 5-fluorouracil (Granci et al, 2008) or oxaliplatin (Toscano et al, 2008) and to increased levels of anti-apoptotic proteins survivin and XIAP in metastatic colorectal cell lines (Huerta et al, 2007).